| Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma YT Tai, PA Mayes, C Acharya, MY Zhong, M Cea, A Cagnetta, J Craigen, ... Blood, The Journal of the American Society of Hematology 123 (20), 3128-3138, 2014 | 437 | 2014 |
| CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications YT Tai, Y Landesman, C Acharya, Y Calle, MY Zhong, M Cea, ... Leukemia 28 (1), 155-165, 2014 | 310 | 2014 |
| APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment YT Tai, C Acharya, G An, M Moschetta, MY Zhong, X Feng, M Cea, ... Blood, The Journal of the American Society of Hematology 127 (25), 3225-3236, 2016 | 302 | 2016 |
| Targeting CD38 suppresses induction and function of T regulatory cells to mitigate immunosuppression in multiple myeloma X Feng, LI Zhang, C Acharya, G An, K Wen, L Qiu, NC Munshi, YT Tai, ... Clinical cancer research 23 (15), 4290-4300, 2017 | 227 | 2017 |
| SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide H Jiang, C Acharya, G An, M Zhong, X Feng, L Wang, N Dasilva, Z Song, ... Leukemia 30 (2), 399-408, 2016 | 223 | 2016 |
| Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma YT Tai, BY Chang, SY Kong, M Fulciniti, G Yang, Y Calle, Y Hu, J Lin, ... Blood, The Journal of the American Society of Hematology 120 (9), 1877-1887, 2012 | 198 | 2012 |
| Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication G An, C Acharya, X Feng, K Wen, M Zhong, L Zhang, NC Munshi, L Qiu, ... Blood, The Journal of the American Society of Hematology 128 (12), 1590-1603, 2016 | 163 | 2016 |
| Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma L Shi, X Qin, H Wang, Y Xia, Y Li, X Chen, L Shang, YT Tai, X Feng, ... Oncotarget 8 (12), 18792, 2017 | 110 | 2017 |
| Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells M Cea, A Cagnetta, S Adamia, C Acharya, YT Tai, M Fulciniti, H Ohguchi, ... Blood, The Journal of the American Society of Hematology 127 (9), 1138-1150, 2016 | 103 | 2016 |
| The Impact of Clone Size on the Prognostic Value of Chromosome Aberrations by Fluorescence In Situ Hybridization in Multiple Myeloma G An, Z Li, YT Tai, C Acharya, Q Li, X Qin, S Yi, Y Xu, X Feng, C Li, J Zhao, ... Clinical cancer research 21 (9), 2148-2156, 2015 | 100 | 2015 |
| Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity A Cagnetta, M Cea, T Calimeri, C Acharya, M Fulciniti, YT Tai, ... Blood, The Journal of the American Society of Hematology 122 (7), 1243-1255, 2013 | 96 | 2013 |
| APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications YT Tai, L Lin, L Xing, SF Cho, T Yu, C Acharya, K Wen, PA Hsieh, J Dulos, ... Leukemia 33 (2), 426-438, 2019 | 79 | 2019 |
| Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients QL An G, Qin X, Acharya C, Xu Y, Deng S, Shi L, Zang M, Sui W, Yi S, Li Z ... Annals of Hematology, 2014 | 69* | 2014 |
| miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth M Fulciniti, N Amodio, RL Bandi, A Cagnetta, MK Samur, C Acharya, ... Blood cancer journal 6 (1), e380-e380, 2016 | 61 | 2016 |
| Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics A Cagnetta, S Adamia, C Acharya, F Patrone, M Miglino, A Nencioni, ... Leukemia research 38 (6), 649-659, 2014 | 58 | 2014 |
| Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies C Thongprayoon, P Acharya, C Acharya, J Chenbhanich, T Bathini, ... Osteoporosis International 29, 1737-1745, 2018 | 52 | 2018 |
| APO866 increases antitumor activity of cyclosporin-A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells A Cagnetta, I Caffa, C Acharya, D Soncini, P Acharya, S Adamia, I Pierri, ... Clinical cancer research 21 (17), 3934-3945, 2015 | 36 | 2015 |
| Incidence and characteristics of kidney stones in patients on ketogenic diet: a systematic review and meta-analysis P Acharya, C Acharya, C Thongprayoon, P Hansrivijit, SR Kanduri, ... Diseases 9 (2), 39, 2021 | 30 | 2021 |
| Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström Macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status M Cea, A Cagnetta, C Acharya, P Acharya, YT Tai, C Yang, D Lovera, ... Clinical Cancer Research 22 (24), 6099-6109, 2016 | 23 | 2016 |
| Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment G An, C Acharya, S Deng, S Yi, Y Xu, X Qin, W Sui, Z Li, L Shi, M Zang, ... Experimental hematology 43 (3), 168-176. e2, 2015 | 22 | 2015 |
